Touting Dubious Remdesivir Over promising Hydroxychoroquine for Treating COVID-19 – Stephen Lendman

Astonishingly in 2016, “80 prescription drug advertisements were televised every hour, totaling 1,920 drug ads directed at American viewers per day,” the Emory Law analysis explained.

It’s a bonanza for US cable and broadcast channels, providing about “8% of their ad revenue.”

Studies show Americans on average watch about five hours of television daily — what noted journalist Edward R. Murrow long  ago called “the opiate of the people.”  

It has everything to sell, mostly nothing to tell about major world and national issues — propaganda masquerading as news and information.

Pharmaceutical industry analyst Michael Yee expects Gilead to earn $525 million in sales revenue this year from the drug, $2.1 billion in 2021 — a bonanza for the company, courtesy of US taxpayers and Big Government collusion with Big Pharma.

Hydroxychloroquine is potentially more promising in treating COVID-19 patients.

Evidence shows it inhibits coronavirus infections and their spread — why Big Pharma wants the drug falsely discredited as ineffective and dangerous.

Drug companies want nothing competing with a potential profit-making bonanza that awaits from mass-vaxxing — no matter how toxic to inoculated individuals.

Touting Dubious Remdesivir Over promising Hydroxychoroquine for Treating COVID-19

Published by TCTTNews

Sharing real news, information & analysis.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: